# Keith Adams

> Keith Adams is a seed investor at Pebblebed (San Francisco) backing Software and Consulting. See 4 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Pebblebed](https://shizune.co/investors/profile/pebblebed)
- Location: San Francisco, United States
- Total investments: 4
- Last investment: Dec 2025
- Lead investor: 50%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/keith-adams-1b45185
- X (Twitter): https://twitter.com/keithmadams
- Website: https://pebblebed.com
- Facebook: https://facebook.com/kma

Keith Adams is a seed investor at Pebblebed in San Francisco focused on Software and Consulting. Keith is One of These Computer People. After a long engineering career (VMware, Facebook, Slack) he co-founded Pebblebed, an early stage VC firm.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Software | 1 | 25% |
| Consulting | 1 | 25% |
| Therapeutics | 1 | 25% |
| Biotechnology | 1 | 25% |
| Manufacturing | 1 | 25% |

9 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 2 | 50% |
| Series A | 1 | 25% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Lemurian Labs | Lemurian Labs has created a universal platform that works across any hardware and spans compiler technology and runtime orchestration. This streamlined, hardware-agnostic approach simplifies AI development, enabling organizations to write code once and deploy it seamlessly across edge, cloud and on-premise environments. By cutting through thecomplexity of fragmented software ecosystems, Lemurian Labs empowers businesses to build and scale AI efficiently, affordably and responsibly—unlocking the full potential of AI innovation without proprietary constraints. | $28M | Series A | Dec 03, 2025 |  |
| Adaptive | Adaptive is a management and technology consulting company specializing in technology strategy, governance, solution development, and risk management, with a focus on artificial intelligence solutions. | $7M | Seed | Apr 22, 2025 |  |
| Meliora Therapeutics | Meliora Therapeutics is a biotech startup that is developing a machine learning-driven platform to identify the true mechanisms of action of oncology medications. | $11M | Seed | Sep 29, 2022 |  |
| Meliora Therapeutics | Meliora Therapeutics is a biotech startup that is developing a machine learning-driven platform to identify the true mechanisms of action of oncology medications. | $11M | Seed | Sep 29, 2022 |  |

4 of 4 investments shown.

## Co-investors
- [Communitas Capital Partners](https://shizune.co/investors/profile/communitas-capital-partners) — VC Fund, 5 deals together
- [BrightEdge Fund](https://shizune.co/investors/profile/brightedge-fund) — VC Fund, 3 deals together
- [Axial VC](https://shizune.co/investors/profile/axial-vc) — VC Fund, 2 deals together
- [HOF Capital](https://shizune.co/investors/profile/hof-capital) — VC Fund, 2 deals together
- [Obvious Ventures](https://shizune.co/investors/profile/obvious-ventures) — VC Fund, 2 deals together
- [Village Global](https://shizune.co/investors/profile/village-global-2) — VC Fund, 2 deals together

## About Pebblebed

VC Fund · San Francisco, United States

Pebblebed is a combination early-stage venture fund/intentional learning community for technologists

2 contacts available at Pebblebed.

| Name | Title | Profile |
| --- | --- | --- |
| Keith Adams | Partner | https://shizune.co/investors/profile/keith-adams-3 |
| Pamela Vagata | General Partner | https://shizune.co/investors/profile/pamela-vagata |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Keith Adams invest in?

Keith Adams invests primarily in Software, Consulting and Therapeutics startups, most often at Seed and Series A stage. Most of the 4 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Keith Adams last invest?

The most recent investment recorded for Keith Adams closed in Dec 2025. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co